pros and cons tirzepatide of microdosing GLP-1 agonists—using doses below FDA-approved levels for T2D or obesity—is rapidly gaining traction as an off-label strategy to improve tolerability, tailor titration, manage costs Microdosing tirzepatide tirzepatide obesity trial non-diabetic pros

The column was washed with 10 mL of binding buffer, followed by 10 mL of wash buffer, before eluting the bound proteins using 3 mL of elution buffer

Ahead, see our picks for the four best food logging apps for people on GLP-1s

are the most impressive weight-loss tools weve ever seen

Nonscale wins matter: better labs, fewer cravings, looser clothes, easier breathing, less joint pain, better mood

According to the Evaluate consultancys 2026 Preview report, Mounjaro and Zepbound are projected to collectively generate more than $45 billion in global sales in 2026, overtaking Mercks Keytruda to become the worlds best-selling drug